Page last updated: 2024-08-17

medroxyprogesterone acetate and Cushing Syndrome

medroxyprogesterone acetate has been researched along with Cushing Syndrome in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (8.33)	18.7374
1990's	7 (58.33)	18.2507
2000's	2 (16.67)	29.6817
2010's	2 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Irish, A; Kong, WY; Leedman, P	1
Jeong, EG; Kim, ES; Seo, Y	1
Hembree, W; Hill, M; Krueger, RB	1
Cove, DH; Dean, S; Malik, KJ; Wakelin, K; Wood, PJ	1
Nussey, SS; Shotliff, K	1
Bishara, J; Blum, I; Dux, S; Marom, D; Pitlik, S	1
Isacson, C; New, MI; Newfield, RS; Spitz, IM	1
Learoyd, D; McElduff, A	1
Buysschaert, M; Donckier, JE; Michel, LA	1
Day, JL; Gray, IP; Grenfell, A; Rudenski, A; Watts, M; Wiltshire, C	1
Alexander, WD; Merrin, PK	1
Drucker, DJ; Goss, P; Siminoski, K	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Cushing Syndrome

Article	Year
Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Annals of clinical biochemistry, 1996, Volume: 33 ( Pt 3) Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Cushing Syndrome; Depression, Chemical; Female; Humans; Hypothalamo-Hypophyseal System; Medroxyprogesterone Acetate; Middle Aged; Pituitary-Adrenal System	1996

Other Studies

11 other study(ies) available for medroxyprogesterone acetate and Cushing Syndrome

Article	Year
A case of iatrogenic Cushing syndrome and apparent mineralocorticoid excess presenting with accelerated hypertension and proteinuria. Internal medicine journal, 2014, Volume: 44, Issue:9 Topics: Antineoplastic Agents, Hormonal; Cushing Syndrome; Female; Humans; Hypertension; Iatrogenic Disease; Medroxyprogesterone Acetate; Middle Aged; Mineralocorticoid Excess Syndrome, Apparent; Proteinuria; Treatment Outcome	2014
Cushing's syndrome with adrenal suppression and masked hyperandrogenism by high-dose medroxyprogesterone acetate for treatment of endometrial cancer in a young woman with polycystic ovarian syndrome. Endocrine, 2015, Volume: 50, Issue:2 Topics: Adult; Antineoplastic Agents, Hormonal; Cushing Syndrome; Endometrial Neoplasms; Female; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome	2015
Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing's syndrome and adrenal insufficiency. Sexual abuse : a journal of research and treatment, 2006, Volume: 18, Issue:2 Topics: Adrenal Insufficiency; Adult; Aggression; Contraceptive Agents, Male; Cushing Syndrome; Humans; Male; Medroxyprogesterone Acetate; Pedophilia; Pituitary-Adrenal System	2006
Medroxyprogesterone acetate induced Cushing's syndrome. British journal of clinical pharmacology, 1997, Volume: 44, Issue:3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cushing Syndrome; Female; Humans; Medroxyprogesterone Acetate; Middle Aged	1997
Medroxyprogesterone acetate-induced secondary adrenal insufficiency. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:1 Topics: Adrenal Insufficiency; Cushing Syndrome; Diagnosis, Differential; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners	1998
Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clinical endocrinology, 2001, Volume: 54, Issue:3 Topics: Adolescent; Contraceptives, Oral, Synthetic; Cushing Syndrome; Endometrial Hyperplasia; Female; Glucocorticoids; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Mifepristone; Osteoporosis; Progesterone; Uterus	2001
Medroxyprogesterone induced Cushing's syndrome. Australian and New Zealand journal of medicine, 1990, Volume: 20, Issue:6 Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Cushing Syndrome; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate	1990
Cushing syndrome and medroxyprogesterone acetate. Lancet (London, England), 1990, May-05, Volume: 335, Issue:8697 Topics: Adrenal Insufficiency; Aged; Antineoplastic Agents; Cushing Syndrome; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate	1990
Cushing's syndrome and medroxyprogesterone acetate. Lancet (London, England), 1990, Jul-28, Volume: 336, Issue:8709 Topics: Aged; Antineoplastic Agents; Cushing Syndrome; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate	1990
Cushing's syndrome induced by medroxyprogesterone. BMJ (Clinical research ed.), 1990, Aug-11, Volume: 301, Issue:6747 Topics: Aged; Antineoplastic Agents; Cushing Syndrome; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate	1990
The Cushing syndrome induced by medroxyprogesterone acetate. Annals of internal medicine, 1989, Nov-01, Volume: 111, Issue:9 Topics: Adrenocorticotropic Hormone; Adult; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cushing Syndrome; Female; Humans; Hydrocortisone; In Vitro Techniques; Kidney Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pituitary Gland; Pro-Opiomelanocortin; RNA, Messenger	1989